Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: A systematic review and economic evaluation
C. Green, J. Dinnes, I. Takeda, J. Shepherd, D. Hartwell, C. Cave, E. Payne, B.H. Cuthbertson
Research output: Contribution to journal › Article › peer-review
31Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: A systematic review and economic evaluation'. Together they form a unique fingerprint.